The FDA has accepted a biologics license application from Inovio for a potential treatment for adults with recurrent respiratory papillomatosis. Although the application was filed under the ...
The FDA has been an agency under fire, from controversial staff appointees, deep staffing cuts to being openly questioned by ...
Because the Food and Drug Administration doesn’t routinely test generic drugs for quality, ProPublica engaged an independent ...
16don MSN
FDA Singapore trip sparks questions
The FDA sent 31 staffers to a Singapore conference during the shutdown, records show, raising questions of optics, spending ...
The Food and Drug Administration is scrutinizing the common practice of giving coronavirus and flu shots together, signaling a reversal of years of federal guidance and a broader crackdown on ...
The mHealth Regulatory Coalition (MRC) recently released “A Call for Clarity: Open Questions on the Scope of FDA Regulation of mHealth," which is a 60-page paper that focuses on two fundamental ...
Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ:INO) stock plunged 21% Monday after the FDA raised concerns about the company’s accelerated approval pathway for its RRP treatment candidate.
Alzheimer’s disease is a devastating condition that affects more than 7 million Americans, according to the Alzheimer’s Association. As the Baby Boomer generation ages, this number is estimated to ...
Genepro Whey protein powder is recalled across the U.S. for undeclared milk allergen. The product is mislabeled as "allergen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback